Morphine 6-glucuronide and morphine 3-glucuronide as molecular chameleons with unexpected lipophilicity. 1991

P A Carrupt, and B Testa, and A Bechalany, and N el Tayar, and P Descas, and D Perrissoud
Institut de Chimie Thérapeutique, Ecole de Pharmacie, Université de Lausanne, Switzerland.

Morphine 6-glucuronide, but not morphine 3-glucuronide, is a highly potent opiate receptor agonist. In fact, there is converging evidence that much of the analgesic effect occurring after morphine treatment in humans is due to this metabolite rather than to the parent drug. Yet glucuronides as a rule are considered as highly polar metabolites unable to cross the blood-brain barrier and rapidly excreted by the urinary and/or biliary routes. Here, we report that morphine 6-glucuronide, and to a lesser extent morphine 3-glucuronide, are far more lipophilic than predicted, and in fact not much less lipophilic than morphine itself. Force-field and quantum mechanical calculations indicate that the two glucuronides can exist in conformational equilibrium between extended and folded forms. The extended conformers, because they efficiently expose their polar groups, must be highly hydrophilic forms predominating in polar media such as water; in contrast, the folded conformers mask part of their polar groups, thus being more lipophilic and likely to predominate in media of low polarity such as biological membranes.

UI MeSH Term Description Entries
D007202 Indicators and Reagents Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant & Hackh's Chemical Dictionary, 5th ed, p301, p499) Indicator,Reagent,Reagents,Indicators,Reagents and Indicators
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D008968 Molecular Conformation The characteristic three-dimensional shape of a molecule. Molecular Configuration,3D Molecular Structure,Configuration, Molecular,Molecular Structure, Three Dimensional,Three Dimensional Molecular Structure,3D Molecular Structures,Configurations, Molecular,Conformation, Molecular,Conformations, Molecular,Molecular Configurations,Molecular Conformations,Molecular Structure, 3D,Molecular Structures, 3D,Structure, 3D Molecular,Structures, 3D Molecular
D009022 Morphine Derivatives Analogs or derivatives of morphine. Morphines
D002151 Calorimetry The measurement of the quantity of heat involved in various processes, such as chemical reactions, changes of state, and formations of solutions, or in the determination of the heat capacities of substances. The fundamental unit of measurement is the joule or the calorie (4.184 joules). (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
D003196 Computer Graphics The process of pictorial communication, between human and computers, in which the computer input and output have the form of charts, drawings, or other appropriate pictorial representation. Computer Graphic,Graphic, Computer,Graphics, Computer

Related Publications

P A Carrupt, and B Testa, and A Bechalany, and N el Tayar, and P Descas, and D Perrissoud
January 1997, European journal of pain (London, England),
P A Carrupt, and B Testa, and A Bechalany, and N el Tayar, and P Descas, and D Perrissoud
December 2014, British journal of anaesthesia,
P A Carrupt, and B Testa, and A Bechalany, and N el Tayar, and P Descas, and D Perrissoud
January 1991, European journal of pharmacology,
P A Carrupt, and B Testa, and A Bechalany, and N el Tayar, and P Descas, and D Perrissoud
January 1995, Brain research bulletin,
P A Carrupt, and B Testa, and A Bechalany, and N el Tayar, and P Descas, and D Perrissoud
June 1996, British journal of clinical pharmacology,
P A Carrupt, and B Testa, and A Bechalany, and N el Tayar, and P Descas, and D Perrissoud
June 2016, Clinical pharmacokinetics,
P A Carrupt, and B Testa, and A Bechalany, and N el Tayar, and P Descas, and D Perrissoud
April 1996, Pain,
P A Carrupt, and B Testa, and A Bechalany, and N el Tayar, and P Descas, and D Perrissoud
November 1992, British journal of clinical pharmacology,
P A Carrupt, and B Testa, and A Bechalany, and N el Tayar, and P Descas, and D Perrissoud
December 2017, Clinical pharmacokinetics,
Copied contents to your clipboard!